Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
918
total citations
- FWCI
- 60.21
- Percentile
- 100%
- References
- 32
Citations per year
Authors
77Topics & keywords
Topics
Keywords
- Edaravone
- Amyotrophic lateral sclerosis
- Placebo
- Medicine
- Physical medicine and rehabilitation
- Double blind
- Multiple sclerosis
- Anesthesia
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.